Skip to main content
Clinical Trials/DRKS00025122
DRKS00025122
Completed
Phase 2

Means to improve cognition in healthy elderly and patients with mild cognitive impairment – from training to non-invasive brain stimulation - Combination therapy of tACS and cognitive training for the treatment of MCI

niversitätsmedizin Göttingen0 sites77 target enrollmentMay 10, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
MCI (Mild Cognitive Impairment)
Sponsor
niversitätsmedizin Göttingen
Enrollment
77
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2021
End Date
October 28, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsmedizin Göttingen

Eligibility Criteria

Inclusion Criteria

  • 1\. Mild cognitive impairment (MCI) or cognitive ability in the context of healthy aging.
  • 2\. The ability to voluntarily give consent to participate in the study.

Exclusion Criteria

  • 1\. Pacemakers, deep brain stimulation
  • 2\. Intracerebral metal implants (e.g. clips after surgery of an intracerebral aneurysms, implantation of an artificial cochlea)
  • 3\. Evidence of epileptic seizures or stroke in the medical history.
  • 4\. Age \< 55 or \> 85 years.
  • 5\. Craniocerebral trauma with loss of consciousness in the previous history
  • 6\. Presence of a serious internal or neurological disease (e.g. untreated tumors, cancer)
  • 7\. Serious neurological or psychiatric diseases (except MCI) (schizophrenia, Parkinson's disease, multiple sclerosis, severe depression)
  • 8\. Glaucoma, retinitis pigmentosa
  • 9\. blood pressure \> 160/100 Hgmm
  • 10\. OPs within the last three months

Outcomes

Primary Outcomes

Not specified

Similar Trials